keyword
https://read.qxmd.com/read/38651569/increased-prevalence-of-germline-pathogenic-chek2-variants-in-individuals-with-pituitary-adenomas
#1
JOURNAL ARTICLE
Sunita M C De Sousa, Ann McCormack, Andreas Orsmond, Angeline Shen, Christopher J Yates, Roderick Clifton-Bligh, Stephen Santoreneos, James King, Jinghua Feng, John Toubia, David J Torpy, Hamish S Scott
CONTEXT: CHEK2 is a cell cycle checkpoint regulator gene with a long-established role as a clinically relevant, moderate risk breast cancer predisposition gene, with greater risk ascribed to truncating variants than missense variants. METHODS: We assessed 165 individuals with pituitary adenomas for CHEK2 variants. The study consisted of a primary cohort of 29 individuals who underwent germline and tumour whole exome sequencing, and a second, independent cohort of 136 individuals who had a targeted next-generation sequencing panel performed on both germline and tumour DNA (n=52) or germline DNA alone (n=84)...
April 23, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38642934/beware-of-epistaxis-fatal-pseudoaneurysm-rupture-30-years-after-treatment-of-acromegaly
#2
JOURNAL ARTICLE
Ana Carreira, Solomon Muna, Ashley B Grossman, Márta Korbonits
We present a fatal complication of treatment in a patient with early-onset acromegaly, treated with two transsphenoidal operations, radiotherapy, radiosurgery and pegvisomant. He was diagnosed in his 30s, and controlled from his 40s, with stable residual tumour within the left cavernous sinus. In his 60s, 30 years after surgery/radiotherapy and 14 years after radiosurgery, he developed recurrent episodes of mild epistaxis. A week later, he presented at his local hospital's emergency department with severe epistaxis and altered consciousness...
April 19, 2024: BMJ Case Reports
https://read.qxmd.com/read/38642577/challenging-diagnosis-of-resistance-to-thyroid-hormone-in-a-patient-with-covid-19-pituitary-microadenoma-and-unusual-response-to-octreotide-long-acting-release-test
#3
JOURNAL ARTICLE
Cristian Petolicchio, Sara Brasili, Stefano Gay, Francesco Cocchiara, Irene Campi, Luca Persani, Lara Vera, Diego Ferone, Federico Gatto
SUMMARY: The resistance to thyroid hormone syndrome (RTHβ) occurs uncommonly and requires a high level of clinical suspicion and specific investigations to reach a precise diagnosis and to avoid unnecessary and potentially harmful therapies. We report a case of a young male patient referred to our unit for SARS-CoV-2 infection and atrial fibrillation with elevated thyroid hormones and non-suppressed thyroid-stimulating hormone (TSH), for which antithyroid therapy was prescribed...
April 1, 2024: Endocrinology, Diabetes & Metabolism Case Reports
https://read.qxmd.com/read/38635073/central-precocious-puberty-secondary-to-postoperative-craniopharyngioma-two-case-reports-and-a-literature-review
#4
JOURNAL ARTICLE
Ruyuan Zhu, Luyao Wang, Ling Zhao, Xiaojing Liu
BACKGROUND: Craniopharyngioma is a common intracranial tumour in children. Clinical manifestations are related to hypothalamic/pituitary deficiencies, visual impairment, and increased intracranial pressure. Defects in pituitary function cause shortages of growth hormone, gonadotropin, corticotropin, thyrotropin, and vasopressin, resulting in short stature, delayed puberty, feebleness, lethargy, polyuria, etc. However, manifestations involving precocious puberty (PP) are rare. CASE REPORT: In both patients, surgical resection was performed after the diagnosis of craniopharyngioma, and breast development occurred postoperatively at one month in one patient and at one year and three months in the other patient...
April 18, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38628594/helical-tomotherapy-craniospinal-irradiation-in-primary-brain-tumours-toxicities-and-outcomes-in-a-peadiatric-and-adult-population
#5
JOURNAL ARTICLE
Julie Savagner, Anne Ducassou, Bastien Cabarrou, Gregory Hangard, Marion Gambart, Anne-Isabelle Bertozzi, Eloise Baudou, Sergio Boetto, Delphine Larrieu, Anne Laprie
OBJECTIVE: As craniospinal irradiation (CSI) is delivered more frequently by helical tomotherapy (HT) with few reports about late effects, we analysed all patients treated in our centre over an 11-year period. METHODS AND MATERIALS: Our study included all patients that underwent CSI by HT, between September 2009 and January 2020, in the Department of Radiation Oncology of the Toulouse Cancer Institute. Acute radiotherapy toxicities were reported and medium- to long-term outcomes analysed...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38604215/endocrine-health-in-survivors-of-adult-onset-cancer
#6
REVIEW
Cornelia S Link-Rachner, Andy Göbel, Nikolai P Jaschke, Tilman D Rachner
Long-term survivors of cancer (ie, the patient who is considered cured or for whom the disease is under long-term control and unlikely to recur) are at an increased risk of developing endocrine complications such as hypothalamic-pituitary dysfunctions, hypogonadisms, osteoporosis, or metabolic disorders, particularly when intensive tumour-directed therapies are applied. Symptom severity associated with these conditions ranges from mild and subclinical to highly detrimental, affecting individual health and quality of life...
April 8, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38576661/stroke-thrombolysis-in-the-context-of-a-pituitary-macroadenoma
#7
Andrew Evans, Jahanzeb Rehan
The presence of an intracranial tumour is a relative or absolute contraindication to stroke thrombolysis by most guidelines across the world. This is based on the risk of iatrogenic symptomatic intracranial haemorrhage related to the tumour. We present a patient where the decision to proceed with thrombolysis was complicated by an incidental finding of an intracranial tumour. The decision was made to proceed with thrombolysis. The patient had excellent functional recovery in the hours after administration and didn't suffer any intracranial haemorrhage...
March 2024: Curēus
https://read.qxmd.com/read/38572274/primary-intramedullary-extradural-ewing-sarcoma
#8
Alameen Damer, Leslie Hamilton, Albert Tu, Donna L Johnston, Raveena Ramphal, Nagwa Wilson
Ewing sarcoma is the second most frequent primary bone tumour of childhood and adolescence. The aim of this report is to describe the imaging, pathology, clinical findings, and treatment of a primary intradural extramedullary Ewing sarcoma with a unique intracranial metastatic component in a pediatric patient. A 14-year-old girl with a history of mood disorders presented to the emergency department with a 3-week history of neck torticollis, cervical pain, paresis, and paresthesia of the upper and lower extremities on the left side...
June 2024: Radiology Case Reports
https://read.qxmd.com/read/38569705/incidence-of-hypopituitarism-in-adults-undergoing-radiotherapy-for-neck-and-head-cancer-protocol-for-a-systematic-review-and-meta-analysis
#9
JOURNAL ARTICLE
Shamir Barros-Sevillano, Miguel Cabanillas-Lazo, Franshesca L Sedano-Chiroque, Camila Escajadillo-Vergara, David Espinoza-Martinez, Isabel Pinedo-Torres
INTRODUCTION: When children with head and neck cancer receive radiation therapy as part of their treatment, a considerable frequency of hypopituitarism has been recognised. However, in adults, it has been little studied and it is possible that patients may be inadvertently affected. The objective is to estimate the incidence of anterior pituitary dysfunction in adults undergoing radiotherapy for head and neck cancer. METHODS AND ANALYSIS: A total of five databases will be used to perform the document search: PubMed, Scopus, Web of Science (Core Collection), Ovid-MEDLINE and Embase...
April 3, 2024: BMJ Open
https://read.qxmd.com/read/38563291/the-lesion-detection-rate-of-ga-68-dotatate-pet-mr-in-multiple-endocrine-neoplasia-type-1
#10
JOURNAL ARTICLE
Jing Gao, Chang Liu, Jinxin Zhou, Yu Pan, Yifan Zhang
INTRODUCTION: The purpose of the study was to determine the usefulness of Ga-68 DOTATATE PET/MR in the identification of tumours in individuals with multiple endocrine neoplasia type 1 (MEN1). METHODS: In this retrospective investigation, five individuals who had tested positive for a hereditary MEN1 variant underwent Ga-68 DOTATATE PET/MR between May 2020 and January 2023. Several types of tumours associated with MEN1 were studied. MEN1-related tumours included pituitary, parathyroid, gastroenteropancreatic, and adrenal...
April 2, 2024: Journal of Medical Imaging and Radiation Oncology
https://read.qxmd.com/read/38539533/machine-learning-analysis-of-post-operative-tumour-progression-in-non-functioning-pituitary-neuroendocrine-tumours-a-pilot-study
#11
JOURNAL ARTICLE
Ziad Hussein, Robert W Slack, Stephanie E Baldeweg, Evangelos B Mazomenos, Hani J Marcus
Post-operative tumour progression in patients with non-functioning pituitary neuroendocrine tumours is variable. The aim of this study was to use machine learning (ML) models to improve the prediction of post-operative outcomes in patients with NF PitNET. We studied data from 383 patients who underwent surgery with or without radiotherapy, with a follow-up period between 6 months and 15 years. ML models, including k-nearest neighbour (KNN), support vector machine (SVM), and decision tree, showed superior performance in predicting tumour progression when compared with parametric statistical modelling using logistic regression, with SVM achieving the highest performance...
March 19, 2024: Cancers
https://read.qxmd.com/read/38528306/pitsurgrt-real-time-localization-of-critical-anatomical-structures-in-endoscopic-pituitary-surgery
#12
JOURNAL ARTICLE
Zhehua Mao, Adrito Das, Mobarakol Islam, Danyal Z Khan, Simon C Williams, John G Hanrahan, Anouk Borg, Neil L Dorward, Matthew J Clarkson, Danail Stoyanov, Hani J Marcus, Sophia Bano
PURPOSE: Endoscopic pituitary surgery entails navigating through the nasal cavity and sphenoid sinus to access the sella using an endoscope. This procedure is intricate due to the proximity of crucial anatomical structures (e.g. carotid arteries and optic nerves) to pituitary tumours, and any unintended damage can lead to severe complications including blindness and death. Intraoperative guidance during this surgery could support improved localization of the critical structures leading to reducing the risk of complications...
March 25, 2024: International Journal of Computer Assisted Radiology and Surgery
https://read.qxmd.com/read/38521632/genetic-diagnosis-in-acromegaly-and-gigantism-from-research-to-clinical-practice
#13
REVIEW
Claudia Ramírez-Rentería, Laura C Hernández-Ramírez
It is usually considered that only 5% of all pituitary neuroendocrine tumours are due to inheritable causes. Since this estimate was reported, however, multiple genetic defects driving syndromic and nonsyndromic somatotrophinomas have been unveiled. This heterogeneous genetic background results in overlapping phenotypes of GH excess. Genetic tests should be part of the approach to patients with acromegaly and gigantism because they can refine the clinical diagnoses, opening the possibility to tailor the clinical conduct to each patient...
March 13, 2024: Best Practice & Research. Clinical Endocrinology & Metabolism
https://read.qxmd.com/read/38504608/is-proton-beam-therapy-always-better-than-photon-irradiation-lessons-from-two-cases
#14
Michelle P Li, Adam Yeo, Roshini Gunewardena, Gabrielle Drum, Kirsty Wiltshire, Claire Phillips, Joseph Sia, Greg Wheeler, Lisa Hall
Proton beam therapy (PBT) is increasingly used to treat cancers, especially in the paediatric and adolescent and young adult (AYA) population. As PBT becomes more accessible, determining when PBT should be used instead of photon irradiation can be difficult. There is a need to balance patient, tumour and treatment factors when making this decision. Comparing the dosimetry between these two modalities plays an important role in this process. PBT can reduce low to intermediate doses to organs at risk (OAR), but photon irradiation has its dosimetric advantages...
March 20, 2024: Journal of Medical Radiation Sciences
https://read.qxmd.com/read/38499816/prolactin-secreting-tumors-dopamine-agonists-and-pregnancy-a-longitudinal-experience-of-a-tertiary-neuroendocrine-center
#15
JOURNAL ARTICLE
Nunzia Prencipe, Chiara Bona, Daniela Cuboni, Alessandro Maria Berton, Fabio Bioletto, Emanuele Varaldo, Luigi Simone Aversa, Michela Sibilla, Valentina Gasco, Ezio Ghigo, Silvia Grottoli
PURPOSE: Prolactin (PRL)-secreting tumours are associated with infertility and can be reverted by dopamine agonist (DA) therapy. The suspension of DA is recommended once pregnancy is established, as all DAs cross the placenta. The aim of the study was to evaluate the rate of maternal-foetal complications in women treated with cabergoline (CAB) or bromocriptine (BRM) for prolactinoma during gestation and the effect of pregnancy on prolactinoma progression. METHODS: This was a retrospective observational study involving 43 women affected by prolactinoma who became pregnant during therapy with CAB or BRM for a total of 58 pregnancies...
March 18, 2024: Pituitary
https://read.qxmd.com/read/38497399/ectopic-acth-syndrome-in-the-course-of-acth-secreting-pancreatic-neuroendocrine-tumour-in-a-patient-with-a-pituitary-lesion-diagnostic-challenges-and-individual-approach
#16
JOURNAL ARTICLE
Joanna Sobolewska, Łukasz Działach, Wioleta Respondek, Agnieszka Wojciechowska-Luźniak, Przemysław Witek
Not required for Clinical Vignette.
2024: Endokrynologia Polska
https://read.qxmd.com/read/38497398/pituitary-apoplexy-as-the-first-manifestation-of-non%C3%A2-functioning-pituitary-neuroendocrine-tumour
#17
JOURNAL ARTICLE
Lukasz Dzialach, Joanna Sobolewska, Wioleta Respondek, Agnieszka Wojciechowska-Luzniak, Przemyslaw Witek
Not required for a Clinical Vignette.
2024: Endokrynologia Polska
https://read.qxmd.com/read/38493773/arginine-vasopressin-deficiency-in-children-with-craniopharyngioma-and-cerebral-germ-cell-tumour-two-sides-of-the-same-coin-clinical-and-radiological-features
#18
JOURNAL ARTICLE
Sabrina Criscuolo, Cristina Partenope, Mario Tortora, Ved Bhushan Arya, Assunta Albanese
INTRODUCTION: Paediatric brain tumours in the sellar-suprasellar region (SSR) are often associated with arginine vasopressin peptide deficiency (AVPD), either at diagnosis caused by the tumour itself or during follow-up as consequence of treatments. The purpose of this research is to retrospectively describe the neuroradiological characteristics and the timing of AVPD development in a cohort of paediatric patients with craniopharyngioma (CP) or germ cell tumours (GCT). METHODS: We evaluated brain MRI at tumour diagnosis and at the onset of AVPD, as well as recorded clinical, endocrinological and histopathological data, treatments, and outcome...
March 15, 2024: Hormone Research in Pædiatrics
https://read.qxmd.com/read/38483762/pituitary-tumours-without-distinct-lineage-differentiation-express-stem-cell-marker-sox2
#19
JOURNAL ARTICLE
Nèle F Lenders, Tanya J Thompson, Jeanie Chui, Julia Low, Warrick J Inder, Peter E Earls, Ann I McCormack
CONTEXT: The recent WHO 2022 Classification of pituitary tumours identified a novel group of 'plurihormonal tumours without distinct lineage differentiation (WDLD)'. By definition, these express multiple combinations of lineage commitment transcription factors, in a monomorphous population of cells. OBJECTIVES: To determine the expression of stem cell markers (SOX2, Nestin, CD133) within tumours WDLD, immature PIT-1 lineage and acidophil stem cell tumours, compared with committed cell lineage tumours...
March 14, 2024: Pituitary
https://read.qxmd.com/read/38482632/real-world-experience-with-11c-methionine-pet-in-the-management-of-acromegaly
#20
JOURNAL ARTICLE
Linus Haberbosch, James MacFarlane, Olympia Koulouri, Daniel Gillett, Andrew S Powlson, Sue Oddy, David J Halsall, Kevin A Huynh, Jonathan Jones, Heok K Cheow, Joachim Spranger, Knut Mai, Christian Strasburger, Richard J Mannion, Mark Gurnell
BACKGROUND: L-[methyl-11C]-methionine-positron emission tomography (Met-PET) is a potentially important imaging adjunct in the diagnostic workup of pituitary adenomas, including somatotroph tumours. Met-PET can identify residual or occult disease and make definitive therapies accessible to a subgroup of patients who would otherwise require lifelong medical therapy. However, existing data on its use are still limited to small case series. Here, we report the largest single centre experience (N=61) in acromegaly...
March 14, 2024: European Journal of Endocrinology
keyword
keyword
88408
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.